Phase II Trial in Advanced Non-Small Cell Lung Cancer with Ifosfamide, Mitomycin and Cisplatinum
作者： C. Garcíá Girón , M. González Barón , A. Ordóñez Gallego , J. Feliu Battle , A. Sánchez Durán
DOI: 10.1159/000418864
关键词:
摘要: SummaryThe combination treatment using ifosfamide (4g/m2) with uroprotective mesna, mitomycin (6mg/m2), and cisplatinum (100mg/m2) (IMP) was evaluated in 51 patients advanced non-small cell lung
karger.com 
sci-hub.st 参考文章(0)